Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)
Sponsor: Jiong Wu
Summary
This study is the first prospective randomized study assessing the safety and patient-reported outcomes of immediate one-stage IBBR compared with those of two-stage IBBR with TiLoop® Bra.
Official title: A Randomized Multicenter, Open, Prospective, Controlled Study-comparison of the Safety of Immediate One-stage Implant Based Breast Reconstruction(IBBR) Versus Two-stage Expander-Implant IBBR Augmented With TiLoop® Bra.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
440
Start Date
2018-06-01
Completion Date
2024-09-30
Last Updated
2024-06-21
Healthy Volunteers
No
Conditions
Interventions
Immediate IBBR+TiLoop®Bra
Patients will receive immediate implant reconstruction following mastectomy using TiLoop®Bra
Immediate-delayed IBBR+TiLoop®Bra
Patients will receive immediate-delayed implant reconstruction following mastectomy using TiLoop®Bra
Locations (11)
Sun Yat-sen Memorial Hospital,Sun Yat-sen University
Guangzhou, Guangdong, China
Guangdong Women and Children Hospital
Guangzhou, Guangdong, China
Hebei Cancer Hospital
Shijiazhuang, Hebei, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China
The first hospital of China medical university
Shengyang, Liaoning, China
Liaoning Cancer Hospital & Insitute
Shenyang, Liaoning, China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Cancer Hospital/ Institute, Fudan University
Shanghai, Shanghai Municipality, China
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
The Second Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China